Millennium and UCB Collaborate on Inflammation
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 57 (Table of Contents)
Published: 5 Mar-2005
DOI: 10.3833/pdr.v2005.i57.706 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
UCB Pharma’s Celltech Antibody Research Centre of Excellence and Millennium Pharmaceuticals entered into an agreement for the research, development and commercialization of treatments for inflammation...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS